Drug-resistant epilepsy is seen in a significant fraction of epilepsy patients.

Cell therapy is one of the emerging strategies investigated rigorously in preclinical models of epilepsy.

GABA-ergic progenitor cell grafts derived from multiple sources have ability to reduce seizures.

Several issues need resolution for clinical translation of GABA-ergic cell therapy for epilepsy.